Two PI3K inhibitors were investigated and both BKM120 and GDC0980 effectively inhibited cellular and clonogenic growth in 6 HNSCC cells, both HPV-positive as well as HPV-negative. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.